Medpace Holdings (MEDP) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Medpace (MEDP) PT Raised to $35.50 at Jefferies; Reiterates Hold
February 28, 2017 9:26 AM ESTJefferies raised its price target on Medpace (NASDAQ: MEDP) to $35.50 (from $34.00) while maintaining a Hold rating. Guidance targets revenue growth of ~7.5% (~8% CC), below consensus' 11.4%. Yet, guidance does bracket Net Income and EPS estimates.
Analyst David Windley commented, "Medpace boasts eye-popping margin,... More
